ストックスクリーナーアプリを入手
198.19
3.18%
6.11
アフターアワーズ：
198.19
前日終値:
$192.08
開ける：
$193.63
24時間の取引高:
679.75K
Relative Volume:
0.79
時価総額：
$12.72B
収益：
$13.84B
当期純損益:
$1.10B
株価収益率:
19.02
EPS:
10.4185
ネットキャッシュフロー:
$1.49B
1週間 パフォーマンス:
+5.48%
1か月 パフォーマンス:
-0.23%
6か月 パフォーマンス:
+69.87%
1年 パフォーマンス:
+43.85%
1日の値動き範囲:
$193.39
$198.26
1週間の範囲:
$186.61
$199.15
52週間の値動き範囲:
$101.00
$202.69
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
198.19 | 12.33B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
374.90 | 80.16B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
166.36 | 14.04B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.35 | 11.70B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
104.19 | 10.03B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
Best Growth Stocks to Buy for June 9th - Yahoo! Finance Canada
Best Value Stocks to Buy for June 9th - Yahoo Finance Singapore
DaVita Inc. (DVA) Announces Ninth Amendment to Credit Agreement - GuruFocus
DaVita Expands Term Loan Facility, Enhancing Capital Flexibility - TipRanks
DavitaEnters Ninth Amendment To Credit Agreement With Jpmorgan On June 8, 2026SEC Filing - TradingView
DaVita Secures $500 Million Incremental Term Loan B-2 Under Credit Facility With JPMorgan - TradingView
DaVita Inc. Enters into Ninth Amendment to Credit Agreement for $500 Million Incremental Tranche B-2 Term Loan - marketscreener.com
DaVita Inc. (DVA) Maintains Strong Buy Rating for 120 Days - GuruFocus
DaVita expands comprehensive kidney care through dialysis services - MSN
Bull of the day: DaVita Inc. (DVA) - MSN
Asset turnover of DaVita Inc. – XETR:TRL - TradingView
Cash per share of DaVita Inc. – XETR:TRL - TradingView
Long term debt to total assets ratio of DaVita Inc. – XETR:TRL - TradingView
EBITDA per share of DaVita Inc. – XETR:TRL - TradingView
DaVita Inc. Cash Flow – XETR:TRL - TradingView
DaVita Inc. Statistics – XETR:TRL - TradingView
Assessing DaVita (DVA) Valuation After Strong Q1 2026 Beat And Upgraded Guidance - Yahoo Finance
Why is DaVita HealthCare Partners stock surging today? - Investing.com
DaVita Inc stock (US23804L1035): Q1 2026 revenue tops estimates while valuation stays in focus - AD HOC NEWS
BofA raises DaVita stock price target to $145 on Q1 beat - Investing.com
DaVita Q1 2026 Earnings: Outpatient and Specialty Care Sector ReviewNews and Statistics - IndexBox
Q1 Earnings Highs And Lows: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
DaVita (DVA) Short Interest & Short Float | Updated Jun 2026 $DVA - MarketBeat
Why is DaVita HealthCare Partners stock surging today? By Investing.com - Investing.com UK
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Sound of a Second Chance: DaVita Patients Celebrate Receiving Their Kidney Transplant - DaVita Newsroom
DaVita Expands Comprehensive Kidney Care Through Dialysis Services - Yahoo Finance
DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Best Growth Stocks to Buy for June 4th - Yahoo Finance Singapore
A Look at DaVita Inc (DVA) After 3.8% Gain -- GF Value $172.69 v - GuruFocus
A Look at DaVita Inc (DVA) After 3.8% Gain -- GF Value $172.69 vs Price $195.03 - GuruFocus
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
How The DaVita (DVA) Story Is Shifting With New Analyst Targets And Valuation Assumptions - Yahoo Finance
DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - Yahoo Finance
What are Wall Street analysts' target price for DaVita stock? - MSN
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't - The Motley Fool
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): NYSE-listed dialysis provider trades around late-May levels as inv - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: High Return On Equity Highlights Investment Potential - DirectorsTalk Interviews
DaVita Interactive Trivia: Put your knowledge to the test with these questions - Denver7
DaVita Inc stock (US23804L1035): shares ease near late-May levels - AD HOC NEWS
DaVita Inc. stock (US23918K1088): shares ease while investors watch technical levels after recent ga - AD HOC NEWS
DaVita Inc. stock (US23918K1088): NYSE shares hold steady as investors look toward next earnings dat - AD HOC NEWS
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): shares trade sideways ahead of next earnings as valuation comes in - AD HOC NEWS
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
DaVita (DVA) Revenue BreakdownMain Composition - Moomoo
Two Sides of the "Gift of Life" From DaVita Teammates - ACCESS Newswire
DaVita and Arcosa have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
DaVita Stock Is Up 70% YTD: What the Numbers Say About 2026 - TIKR.com
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
2.57%
0.75%
大文字化:
|
ボリューム (24 時間):